ATE396717T1 - Verfahren zur behandlung von alkoholischer hepatitis - Google Patents

Verfahren zur behandlung von alkoholischer hepatitis

Info

Publication number
ATE396717T1
ATE396717T1 AT04776447T AT04776447T ATE396717T1 AT E396717 T1 ATE396717 T1 AT E396717T1 AT 04776447 T AT04776447 T AT 04776447T AT 04776447 T AT04776447 T AT 04776447T AT E396717 T1 ATE396717 T1 AT E396717T1
Authority
AT
Austria
Prior art keywords
alcoholic hepatitis
treating alcoholic
alpha
subject
ketoalkanoic acid
Prior art date
Application number
AT04776447T
Other languages
English (en)
Inventor
Mitchell Fink
Runkuan Yang
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE396717T1 publication Critical patent/ATE396717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT04776447T 2003-06-13 2004-06-10 Verfahren zur behandlung von alkoholischer hepatitis ATE396717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47863703P 2003-06-13 2003-06-13
US49955203P 2003-09-02 2003-09-02

Publications (1)

Publication Number Publication Date
ATE396717T1 true ATE396717T1 (de) 2008-06-15

Family

ID=33567583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776447T ATE396717T1 (de) 2003-06-13 2004-06-10 Verfahren zur behandlung von alkoholischer hepatitis

Country Status (10)

Country Link
US (1) US20050032891A1 (de)
EP (1) EP1635806B1 (de)
JP (1) JP2007500752A (de)
AT (1) ATE396717T1 (de)
AU (1) AU2004253460B2 (de)
CA (1) CA2528913A1 (de)
DE (1) DE602004014140D1 (de)
ES (1) ES2310755T3 (de)
PT (1) PT1635806E (de)
WO (1) WO2005002563A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101472613A (zh) * 2006-04-12 2009-07-01 R·L·亚历山大 包含丙酮酸烷基酯的组合物及其应用
WO2021216984A1 (en) * 2020-04-24 2021-10-28 The General Hospital Corporation Methods for accelerating alcohol metabolism to alleviate intoxication
CN113197884A (zh) * 2021-06-24 2021-08-03 云南大学 α-酮丁酸在制备预防和/或治疗非酒精性脂肪肝的药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US648380A (en) * 1899-08-28 1900-05-01 Jules A Birsfield Surveying instrument.
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4812479A (en) * 1981-04-01 1989-03-14 The Montefiore Hospital Society Of Western Pennsylvania, Inc. Method for preventing body fat deposition in mammals
DE4114591A1 (de) * 1991-05-04 1992-11-05 Agfa Gevaert Ag Fotografisches verarbeitungsverfahren
AU2694592A (en) * 1991-09-30 1993-05-03 Walser, Mackenzie Methods for treatment of free-radical-mediated tissue injury
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US6086789A (en) * 1996-03-18 2000-07-11 Case Western Reserve University Medical uses of pyruvates
US5667962A (en) * 1996-03-18 1997-09-16 Case Western Reserve University Pyruvate thiolester for the prevention of reperfusion injury
US5876916A (en) * 1996-03-18 1999-03-02 Case Western Reserve University Pyruvate compounds and methods for use thereof
DE60027319T2 (de) * 1999-10-07 2007-04-05 Xanthus Life Sciences, Inc., Montreal Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällen
US6846842B2 (en) * 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
EP1379230A4 (de) * 2001-03-15 2009-01-21 Univ Pittsburgh Verfahren zur verwendung von pyruvat und/oder seiner derivative zur behandlung von durch zytokine vermittelten entzündlichen zuständen
ATE306257T1 (de) * 2002-04-17 2005-10-15 Critical Therapeutics Inc Pharmazeutische zusammensetzung enthaltend ein alpha-ketoalkansäureester oder -amid und milchsäure oder ein milchsäuresalz

Also Published As

Publication number Publication date
WO2005002563A2 (en) 2005-01-13
EP1635806A2 (de) 2006-03-22
AU2004253460A1 (en) 2005-01-13
US20050032891A1 (en) 2005-02-10
EP1635806B1 (de) 2008-05-28
AU2004253460B2 (en) 2007-09-27
WO2005002563A3 (en) 2005-03-17
PT1635806E (pt) 2008-09-09
DE602004014140D1 (de) 2008-07-10
JP2007500752A (ja) 2007-01-18
ES2310755T3 (es) 2009-01-16
CA2528913A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ATE556711T1 (de) Verfahren zur verbesserung der hautqualität
ATE409037T1 (de) Verfahren zur erhöhung der leptinspiegel unter verwendung von nikotinsäureverbindungen
ATA16992000A (de) Verfahren zur herstellung von fettsäurealkylestern
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
DE60321625D1 (de) Verfahren zur Herstellung von Acrylsäure
ATE448293T1 (de) Vorrichtung und verfahren zur herstellung von alkylester
DE60110497D1 (de) Verfahren zur Herstellung von Acrylsäure
ATE546423T1 (de) Verfahren zur herstellung von alkyl(meth)acrylaten
ATE410519T1 (de) Verfahren zur herstellung einer wässrigen acrylamidlösung mit einem biokatalysator
DE60227784D1 (de) Verfahren zur herstellung von alkenylphosphinoxiden oder alkenylphosphinsäureestern
DE60318701D1 (de) Verfahren zur verbesserung der effizienz der tierzüchtung
DE60321626D1 (de) Verfahren zur Herstellung von Acrylsäure
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
DE60336713D1 (de) Verfahren zur nassbehandlung von scheibenförmigen gegenständen
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
EP1651237A4 (de) Verfahren zur behandlung von dermatologischen erkrankungen
EP1200538A4 (de) Verfahren zur behandlung von petroleumsäuren
DE60315741D1 (de) Verfahren zur Herstellung von Acrylsäure
ATE493980T1 (de) Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung
ATE354564T1 (de) Verfahren zur herstellung von 2-hydroxy-4- methylthio-buttersäure-estern
ATE396717T1 (de) Verfahren zur behandlung von alkoholischer hepatitis
DE50115789D1 (de) Verfahren zur verbesserung des regelverhaltens eines abs
ATA136598A (de) Verfahren zur umesterung von alpha-ketocarbonsäureestern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties